NCT03170388

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 741 (actual)
• Sponsor: Bausch Health Americas, Inc. · Industry
• Sex: All
• Age: 9 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris

Detailed description

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris

Conditions

• Acne Vulgaris

Interventions

Type	Name	Description
DRUG	IDP-126 Gel	Gel
DRUG	IDP-126 Component A	Component A
DRUG	IDP-126 Component B	Component B
DRUG	IDP-126 Component C	Component C
DRUG	IDP-126 Vehicle Gel	Vehicle Gel

Timeline

• Start date: 2017-10-05
• Primary completion: 2019-04-23
• Completion: 2019-04-23
• First posted: 2017-05-31
• Last updated: 2021-11-10
• Results posted: 2021-11-10

Locations

34 sites across 2 countries: United States, Canada

Regulatory

• FDA-regulated drug study